Literature DB >> 22351374

Effect of comorbid conditions on adherence to colorectal cancer screening.

Dana J Lukin1, Lina H Jandorf, Rayhana J Dhulkifl, Linda D Thélémaque, Jennifer A Christie, Steven H Itzkowitz, Katherine N Duhamel.   

Abstract

Potential barriers to colorectal cancer (CRC) screening include preexisting medical conditions (comorbidities), physician recommendation, psychosocial factors, and screening preparedness. This study's purpose was to investigate the impact of comorbid conditions on CRC screening among African Americans. A stage-matched randomized clinical trial was performed. Asymptomatic African Americans over age 50, with a primary care physician, and eligible for CRC screening were recruited at The Mount Sinai Hospital from 2005 to 2008. One hundred sixty-one patients were assessed for referral for, and completion of, CRC screening, comorbid conditions, "readiness to change," and number of physician visits within the observation period. Data was compared to a pretrial index to predict the likely effect of comorbid conditions on CRC screening. One hundred fifty-nine patients completed the study; 108 (68.9%) were referred for and 34 (21.2%) completed CRC screening. No demographic characteristics were associated with CRC screening completion. CRC screening referrals were similar for all patients, regardless of comorbidities or clinical visits. Comorbidities rated as having extreme influence on CRC screening showed a trend toward lower screening rates. There was a significant increase in screening rates among participants in advanced stages of readiness at enrollment. These data suggest that while comorbidities did not predict colonoscopy completion, they may play a role in concert with other factors. This is the only study to assess the effect of screening colonoscopy in an African American primary care setting. We must continue to explore interventions to narrow the disparate gap in screening and mortality rates.

Entities:  

Mesh:

Year:  2012        PMID: 22351374      PMCID: PMC3778660          DOI: 10.1007/s13187-011-0303-2

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  26 in total

1.  Clinical practice. Screening for colorectal cancer.

Authors:  David F Ransohoff; Robert S Sandler
Journal:  N Engl J Med       Date:  2002-01-03       Impact factor: 91.245

2.  Correlates of colorectal cancer screening compliance and stage of adoption among siblings of individuals with early onset colorectal cancer.

Authors:  Sharon Manne; Arnold Markowitz; Sidney Winawer; Neal J Meropol; Daniel Haller; William Rakowski; James Babb; Lina Jandorf
Journal:  Health Psychol       Date:  2002-01       Impact factor: 4.267

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

4.  Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings.

Authors:  T F Imperiale; D R Wagner; C Y Lin; G N Larkin; J D Rogge; D F Ransohoff
Journal:  N Engl J Med       Date:  2000-07-20       Impact factor: 91.245

5.  Sociodemographic correlates of stage of adoption for colorectal cancer screening in African Americans.

Authors:  Jennifer Christie; Lina Jandorf; Steven Itzkowitz; Ethan Halm; Kim Freeman; Sheba King; Rayhana Dhulkifl; Michelle McNair; Linda Thelemaque; Catalina Lawsin; Katherine Duhamel
Journal:  Ethn Dis       Date:  2009       Impact factor: 1.847

6.  Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup.

Authors:  S J Winawer; A G Zauber; M J O'Brien; M N Ho; L Gottlieb; S S Sternberg; J D Waye; J Bond; M Schapiro; E T Stewart
Journal:  N Engl J Med       Date:  1993-04-01       Impact factor: 91.245

7.  Relationship between health status and use of screening mammography and Papanicolaou smears among women older than 70 years of age.

Authors:  Louise C Walter; Karla Lindquist; Kenneth E Covinsky
Journal:  Ann Intern Med       Date:  2004-05-04       Impact factor: 25.391

8.  The effect of comorbid illness on receipt of cancer screening by older people.

Authors:  Mitchell T Heflin; Eugene Z Oddone; Carl F Pieper; Bruce M Burchett; Harvey Jay Cohen
Journal:  J Am Geriatr Soc       Date:  2002-10       Impact factor: 5.562

Review 9.  The natural history of colorectal cancer. Opportunities for intervention.

Authors:  S J Winawer; A G Zauber; E Stewart; M J O'Brien
Journal:  Cancer       Date:  1991-02-15       Impact factor: 6.860

10.  The relationship of physician medical interview style to patient satisfaction.

Authors:  K D Bertakis; D Roter; S M Putnam
Journal:  J Fam Pract       Date:  1991-02       Impact factor: 0.493

View more
  11 in total

1.  Patient Non-adherence and Cancellations Are Higher for Screening Colonoscopy Compared with Surveillance Colonoscopy.

Authors:  Michael Greenspan; Navdeep Chehl; Krista Shawron; Lisa Barnes; Hong Li; Elizabeth Avery; Shannon Sims; John Losurdo; Sohrab Mobarhan; Joshua Melson
Journal:  Dig Dis Sci       Date:  2015-04-23       Impact factor: 3.199

2.  Adherence to Screening Colonoscopy: Can We Get Our Recommendations to Stick?

Authors:  Melinda C Rogers; Rajesh N Keswani
Journal:  Dig Dis Sci       Date:  2015-10       Impact factor: 3.199

3.  Risk factors of nonadherence to colonoscopy surveillance after polypectomy and its impact on clinical outcomes: a KASID multicenter study.

Authors:  Chung Hyun Tae; Chang Mo Moon; Seong-Eun Kim; Sung-Ae Jung; Chang Soo Eun; Jae Jun Park; Geom Seog Seo; Jae Myung Cha; Sung Chul Park; Jaeyoung Chun; Hyun Jung Lee; Yunho Jung; Jin Oh Kim; Young-Eun Joo; Dong Il Park
Journal:  J Gastroenterol       Date:  2016-11-09       Impact factor: 7.527

Review 4.  Explaining persistent under-use of colonoscopic cancer screening in African Americans: a systematic review.

Authors:  Erica G Bromley; Folasade P May; Lisa Federer; Brennan M R Spiegel; Martijn G H van Oijen
Journal:  Prev Med       Date:  2014-12-04       Impact factor: 4.018

5.  Integrating men's health and masculinity theories to explain colorectal cancer screening behavior.

Authors:  Shannon M Christy; Catherine E Mosher; Susan M Rawl
Journal:  Am J Mens Health       Date:  2013-06-27

6.  Predictors of stage of adoption for colorectal cancer screening among African American primary care patients.

Authors:  Hsiao-Lan Wang; Shannon M Christy; Celette S Skinner; Victoria L Champion; Jeffrey K Springston; Susan M Perkins; Yan Tong; Connie Krier; Netsanet Gebregziabher; Susan M Rawl
Journal:  Cancer Nurs       Date:  2014 Jul-Aug       Impact factor: 2.592

7.  Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study.

Authors:  Carolina Guiriguet; Guillem Pera; Antoni Castells; Pere Toran; Jaume Grau; Irene Rivero; Andrea Buron; Francesc Macià; Carmen Vela-Vallespín; Mercedes Vilarrubí-Estrella; Mercedes Marzo-Castillejo
Journal:  BMC Cancer       Date:  2017-08-07       Impact factor: 4.430

8.  Examining Factors Influencing Colorectal Cancer Screening of Rural Nebraskans Using Data from Clinics Participating in an Accountable Care Organization: A Study Protocol.

Authors:  Lufei Young; Jungyoon Kim; Hongmei Wang; Li-Wu Chen
Journal:  F1000Res       Date:  2015-07-22

Review 9.  Screening for colorectal cancer: the role of the primary care physician.

Authors:  John K Triantafillidis; Constantine Vagianos; Aristofanis Gikas; Maria Korontzi; Apostolos Papalois
Journal:  Eur J Gastroenterol Hepatol       Date:  2017-01       Impact factor: 2.566

10.  Barriers and facilitators associated with colonoscopy completion in individuals with multiple chronic conditions: a qualitative study.

Authors:  Shahnaz Sultan; Melissa R Partin; Phalgoon Shah; Jennifer LeLaurin; Ivette Magaly Freytes; Chandylen L Nightingale; Susan F Fesperman; Barbara A Curbow; Rebecca J Beyth
Journal:  Patient Prefer Adherence       Date:  2017-05-24       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.